Transplant Recipient Candidacy and Perioperative Management
This area covers how patients are selected for solid-organ transplantation and how they are evaluated, monitored, and managed across the transplant journey. It spans the determination of who is a suitable recipient, the testing and risk stratification done before transplantation, and the surveillance and complication recognition that follow. The throughline is patient selection: balancing the expected benefit of a transplant against a candidate's surgical, cardiovascular, infectious, and immunologic risks.
Definition
Transplant recipient candidacy and perioperative management is the body of evaluation, risk-stratification, and surveillance practice that determines whether a patient should undergo organ transplantation and how the patient is monitored and managed before and after the procedure.
Scope
The area orients the reader to the recipient side of transplantation rather than donor or organ-procurement topics. It groups recipient evaluation and candidacy decisions, pre-transplant testing and screening, cardiovascular risk assessment specific to transplant candidates, post-transplant monitoring and surveillance, and the recognition of post-transplant complications. It is a reference-educational overview of how candidacy and perioperative care are organized, not a protocol for managing an individual patient.
Sub-topics
Core questions
- Who is an appropriate candidate for organ transplantation, and what conditions are absolute or relative contraindications?
- What pre-transplant testing and screening establish a candidate's baseline risk and rule out barriers to transplantation?
- How is cardiovascular risk assessed in candidates who frequently have advanced organ failure?
- What surveillance detects rejection, infection, and malignancy after transplantation?
- How are the major post-transplant complications recognized and categorized?
Key concepts
- Patient selection and candidacy
- Absolute and relative contraindications
- Risk-benefit assessment
- Pre-transplant screening (infectious, malignancy, immunologic)
- Cardiovascular risk stratification
- Allograft surveillance
- Net state of immunosuppression
- Allograft rejection and dysfunction
Clinical relevance
Candidacy and perioperative management determine both who can access transplantation and how outcomes are protected once an organ is implanted. Evaluation guidelines such as the KDIGO candidate guideline and the AHA/ACC cardiac statement describe how transplant programs structure these decisions and surveillance schedules. This area describes how recipient care is organized and is not a substitute for individualized clinical judgement.
Epidemiology
End-stage organ failure populations carry a high burden of cardiovascular disease, infection susceptibility, and competing comorbidity, which is why structured candidacy evaluation and post-transplant surveillance are central to transplant practice. Infection and allograft rejection remain leading causes of morbidity after transplantation, shaping the surveillance described in this area.
Evidence & guidelines
The 2020 KDIGO guideline on evaluation and management of kidney transplant candidates and the 2012 AHA/ACC scientific statement on cardiac evaluation among kidney and liver transplant candidates are widely cited frameworks for candidacy and pre-transplant cardiovascular assessment. Reviews of infection and of allograft rejection inform the post-transplant monitoring and complication topics.
Related topics
Seminal works
- chadban-2020
- lentine-2012
- fishman-2007
Frequently asked questions
- What does transplant candidacy assessment decide?
- It decides whether a patient is likely to benefit from transplantation and can tolerate the procedure and lifelong immunosuppression, weighing surgical, cardiovascular, infectious, and psychosocial factors against the expected benefit.
- How does this area differ from donor-focused transplantation topics?
- It concerns the recipient side: evaluating and selecting candidates and managing them before and after transplantation, rather than donor selection, organ procurement, or graft preservation.